Label Decoder
Consult your doctor before stopping this medicine
Official label information
Labeling warns that abrupt or rapid discontinuation may increase seizure risk in people with seizure disorders and that gabapentin should be withdrawn gradually, generally over a minimum of one week, at the prescriber’s discretion.
Plain-language explanation
Some medicines should not be stopped suddenly because symptoms can return or new problems can occur. A clinician can decide whether a gradual change or another plan is appropriate.
What this often means for gabapentin products
Postmarketing reports also describe withdrawal-type symptoms in some people after stopping, sometimes within about 48 hours. This phrase is not an order to continue through anaphylaxis or another emergency; seek urgent care for severe reactions, then involve the clinician about next steps.
Ask your pharmacist
Ask who to contact after hours if you are considering stopping because of a concerning symptom.
Sources
- DailyMed: NEURONTIN (gabapentin) capsules, tablets, and oral solution — U.S. National Library of Medicine
- DailyMed: GRALISE (gabapentin) tablets — U.S. National Library of Medicine
This decoder does not diagnose, set a personal dose, or create a taper schedule. If two instructions conflict, pause and ask the dispensing pharmacist.